More cost-effective cure for hepatitis C may be close

(Loyola University Health System) The cost of treating hepatitis C virus could be cut up to 50 percent if mathematical models are used to predict when patients can safely stop taking direct-acting antiviral medication, according to a new study by researchers at Loyola University Health System and Loyola University Chicago.